Skip to NavigationSkip to content


Merck KGaA commits to continued partnership with Ugandan Government

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit subsidiary Merck Foundation to build healthcare capacity and treatment access in the region, particularly in the areas of cancer, cardiovascular disease, diabetes and infertility.

New hope through Ebola vaccine trial

Ebola image

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during a trial that will pave the way for a more potent version.

The Phase I trial comprised 108 adults from Kampala being given either an Ebola vaccine, a shot for the closely related Marburg virus, both medicines or a placebo.

The Ebola and Marburg vaccines were reported to generate a comparable response in tests involving Ugandan and American volunteers, revealing that they are (so far) safe and generate an immune response in both populations.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches